Medimate BV offers a new health care model: testing at the Point of Care! Strong market demands are identified for
•Improving Quality of Life of Patients
•Decreasing the number of hospitalizations
•More self control and
This in combination with the increased demand for self support of the Dutch population offers great opportunities in the medical market.
Medimate mission is to become the best performing international company for medical systems providing Health Care Solutions for Point of Care diagnostics using innovative Disposable Lab-on-a-Chip nanotechnology.
Our first product is the Medimate Analyzer together with a Disposable Lab-on-a-Chip for self testing on Lithium in Blood by patients with Manic Depressive Illness. Lithium is the number one medication but has the major disadvantage of being severely toxic just above the therapeutic concentration. Patients have to go to the hospital on regular basis to control their medication. Offering a self test gives the possibility to measure “always and everywhere”. By using this “plug and play” analyzer patients will get their results within two minutes without hospital bothering anymore. The Disposable Lab-on-a-Chip will be paid through the Diagnose Behandeling Combinaties (DBCs). Currently about 30.000 patients in the Netherlands are on lithium medication. From an extensive survey under 200 patients about 75% desires to measure at home.
It is Medimates objective to enter the Dutch market in the last quarter of 2008. From April 2008 the Spanish market will be targeted as well. Other countries will follow afterwards. The Medimate Analyzer will be made suitable for professional use as well as for self testing.
Besides measuring Lithium at the Point of Care Medimate is also capable of measuring other species, among many others also Sodium, Potassium, Phosphate, Calcium, Magnesium. In potential all ions can be measured, inorganic as well as organic. Presently Medimate investigates other Point of Care markets as well.
Medimate is the 30th Spin off company from the Mesa+ Institute. The company originates from the BIOS Lab on a Chip group where the ability to measure charged species in whole blood was proven during a PhD project.
Medimate thanks the Foundation Technology and Science (Technologiestichting STW) for their trust and support via the Valorization Grant Phase 1 and 2.
For more information please visit www.medimate.com.
The Medimate Lithium Analyzer with the LICETAS disposable
Lab on a Chip in a process scheme.